Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Schattenberg

Showing results (31-40 of 52) with videos related to

Pageof 6
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 16, 2000
Donor lymphocyte infusions for relapsed multiple myeloma after allogeneic stem-cell transplantation: predictive factors for response and long-term outcomeH M Lokhorst, A Schattenberg, J J Cornelissen, et al.
British Journal of Haematology|October 23, 1997
Outcome of transplantation for standard-risk leukaemia with grafts depleted of lymphocytes after conditioning with an intensified regimenN Schaap, A Schattenberg, B Bär, et al.
Blood|November 15, 1993
Outcome for patients who relapse after allogeneic bone marrow transplantation for chronic myeloid leukemia. Chronic Leukemia Working Party. European Bone Marrow Transplantation GroupW Arcese, J M Goldman, E D'Arcangelo, et al.
Bone Marrow Transplantation|April 6, 2004
Addition of ATG to the conditioning regimen is a major determinant for outcome after transplantation with partially lymphocyte-depleted grafts from voluntary unrelated donorsA Schattenberg, A van der Meer, F Preijers, et al.
Leukemia|March 21, 2003
Quantification of donor and recipient hemopoietic cells by real-time PCR of single nucleotide polymorphismsF Maas, N Schaap, S Kolen, et al.
Leukemia & Lymphoma|February 26, 1999
In relapsed patients after lymphocyte depleted bone marrow transplantation the percentage of donor T lymphocytes correlates well with the outcome of donor leukocyte infusionA Schattenberg, N Schaap, E Van De Wiel-Van Kemenade, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1993
Donor leukocyte infusions for chronic myeloid leukemia relapsed after allogeneic bone marrow transplantationB M Bär, A Schattenberg, E J Mensink, et al.
Blood|March 15, 1990
Allogeneic bone marrow transplantation for leukemia with marrow grafts depleted of lymphocytes by counterflow centrifugationA Schattenberg, T De Witte, F Preijers, et al.
Blood|March 1, 1992
Recombinant human granulocyte-macrophage colony-stimulating factor accelerates neutrophil and monocyte recovery after allogeneic T-cell-depleted bone marrow transplantationT De Witte, A Gratwohl, N Van Der Lely, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 19, 2002
Transplantation of peripheral blood stem cells as compared with bone marrow from HLA-identical siblings in adult patients with acute myeloid leukemia and acute lymphoblastic leukemiaO Ringdén, M Labopin, A Bacigalupo, et al.
Pageof 6

Showing results (31-40 of 52) with videos related to

Sort By:
Pageof 6
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 16, 2000
Donor lymphocyte infusions for relapsed multiple myeloma after allogeneic stem-cell transplantation: predictive factors for response and long-term outcomeH M Lokhorst, A Schattenberg, J J Cornelissen, et al.
British Journal of Haematology|October 23, 1997
Outcome of transplantation for standard-risk leukaemia with grafts depleted of lymphocytes after conditioning with an intensified regimenN Schaap, A Schattenberg, B Bär, et al.
Blood|November 15, 1993
Outcome for patients who relapse after allogeneic bone marrow transplantation for chronic myeloid leukemia. Chronic Leukemia Working Party. European Bone Marrow Transplantation GroupW Arcese, J M Goldman, E D'Arcangelo, et al.
Bone Marrow Transplantation|April 6, 2004
Addition of ATG to the conditioning regimen is a major determinant for outcome after transplantation with partially lymphocyte-depleted grafts from voluntary unrelated donorsA Schattenberg, A van der Meer, F Preijers, et al.
Leukemia|March 21, 2003
Quantification of donor and recipient hemopoietic cells by real-time PCR of single nucleotide polymorphismsF Maas, N Schaap, S Kolen, et al.
Leukemia & Lymphoma|February 26, 1999
In relapsed patients after lymphocyte depleted bone marrow transplantation the percentage of donor T lymphocytes correlates well with the outcome of donor leukocyte infusionA Schattenberg, N Schaap, E Van De Wiel-Van Kemenade, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1993
Donor leukocyte infusions for chronic myeloid leukemia relapsed after allogeneic bone marrow transplantationB M Bär, A Schattenberg, E J Mensink, et al.
Blood|March 15, 1990
Allogeneic bone marrow transplantation for leukemia with marrow grafts depleted of lymphocytes by counterflow centrifugationA Schattenberg, T De Witte, F Preijers, et al.
Blood|March 1, 1992
Recombinant human granulocyte-macrophage colony-stimulating factor accelerates neutrophil and monocyte recovery after allogeneic T-cell-depleted bone marrow transplantationT De Witte, A Gratwohl, N Van Der Lely, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 19, 2002
Transplantation of peripheral blood stem cells as compared with bone marrow from HLA-identical siblings in adult patients with acute myeloid leukemia and acute lymphoblastic leukemiaO Ringdén, M Labopin, A Bacigalupo, et al.
Pageof 6